Phase II Study of Cetuximab (Erbitux) in Combination With Modified FOLFIRI in Patients With Advanced Gastric Cancer Who Failed to First-Line Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2017
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms EFFI; STAGE
- 25 Dec 2009 Actual patient number (61) added as reported by ClinicalTrials.gov.
- 25 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 25 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.